Patient satisfaction, sexual function and decision regret in use of levonorgestrel intrauterine device

Canan Satır Özel, Gökçem Büşra İNANÇ KARAMAN, Ergül Demirçivi Bör, Demirçivi, Ergül, Oğuz Devrim Yardımcı, Mustafa Çakır, Abdülkadir Turgut
In: Anatolian Current Medical Journal · 2023 · doi:10.38053/acmj.1245399 · W4362670883
article OA: green CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study evaluated levonorgestrel-releasing intrauterine device (LNG-IUD) use in 168 patients, finding reduced bleeding frequency, improved hemoglobin/hematocrit, and positive impacts on sexual function and decision regret across various etiologic causes of abnormal uterine bleeding.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-09 · read from full text ⓘ

This paper studied patient satisfaction, sexual function, and decision regret among individuals using a levonorgestrel intrauterine device, using questionnaire-based measures to capture satisfaction and sexual functioning and to quantify regret about the decision to use the device. The key findings reported relationships between levonorgestrel IUD use and patient-reported outcomes across these domains, indicating measurable variability in satisfaction, sexual function, and decision regret. A major limitation is that, based on the provided text, methodological details such as the study design, timing since insertion, sample characteristics, and how causality could be inferred are not specified in the excerpt. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Aim: Abnormal uterine bleeding is a common condition. The etiological cause and treatments are diverse. LNG-IUD can be used to treat abnormal uterine bleeding.It has been shown to reduce the amount of bleeding in patients with menorrhagia and increase hemoglobin and hematocrit (Hct) values. The aim is to investigate the effects of LNG-IUD on hemoglobin, Hct, bleeding pattern, and its effect on sexual function, decision regret, and menorrhagia effects according to the etiologic cause.Material and Method: Our study included patients who underwent LNG-IUD implantation and had been using it for over six months. Patients with a history of postmenopausal or adolescent bleeding, hematologic or oncologic diseases, and a history of drug use that may cause coagulation disorders were excluded. Patients were grouped according to their indications as polyp (n=26), adenomyosis (n=16), leiomyoma (n=27), hyperplasia (n=18), and non-structural causes (n=81). Hemoglobin (Hb) and Hct values were examined before and after the application, and bleeding patterns were questioned. Participants were administered Menorrhagia Impact Questionnaire (MIQ), Arizona Sexual Experience Scale and Decision Regret Scale. Results: 168 patients were included in our study. The average duration of LNG-IUD use was 627.0±319 days and the average age was 43.4±6.1 years. The frequency of bleeding (number of bleedings per year) was 18.0±8.0 before LNG-IUD application and 7.8±8.0 after treatment (p
Full text 2,125 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Keywords

References

- Liu Z, Doan Q, Blumenthal P, Dubois RW. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health 2007; 10: 183–94. - Fraser IS, Critchley HOD, Broder M, Munro MG. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med 2011; 29: 383–90. - Heavy menstrual bleeding: assessment and management. National Institute for Health and Care Excellence (NICE), Clinical Guidelines Vol. 29, 2018, London. - Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, DeSanctis Y, Jensen J. Levonorgestrel-Releasing Intrauterine System for heavy menstrual bleeding improves hemoglobin and ferritin levels. Contraception 2012; 86: 452–457. - Munro MG, Critchley HOD, Broder MS, Fraser IS, FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011; 113: 3–13. - McGahuey CA, Gelenberg AJ, Laukes CA, et al. The Arizona sexual experience scale (ASEX): reliability and validity. J Sex Marital Ther 2000; 26: 25–40 - Soykan A. The reliability and validity of Arizona sexual experiences scale in Turkish ESRD patients undergoing hemodialysis. Int J Impot Res 2004; 16: 531–4. - Bushnell DM, Martin ML, Moore KA, Richter HE, Rubin A, Patrick DL. Menorrhagia Impact Questionnaire: assessing the influence of heavy menstrual bleeding on quality of life. Curr Med Res Opin 2010; 26: 2745–55. Details Primary Language English Subjects Health Care Administration Journal Section Research Article Authors Ergül Demirçivi 0000-0002-4448-3863 Türkiye Oğuz Yardımcı 0000-0003-0838-8241 Türkiye Mustafa Çakır 0000-0002-4963-5651 Türkiye Abdulkadir Turgut 0000-0002-3156-2116 Türkiye Publication Date March 27, 2023 Submission Date January 31, 2023 Acceptance Date February 27, 2023 Published in Issue Year 2023 Volume: 5 Number: 2

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (30)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK